Cancer mRNA vaccines: clinical application progress and challenges
Hang Li,
Lequan Min,
Haotian Du
и другие.
Cancer Letters,
Год журнала:
2025,
Номер
625, С. 217752 - 217752
Опубликована: Апрель 28, 2025
Язык: Английский
Circular RNA, A Molecule with Potential Chemistry and Applications in RNA-based Cancer Therapeutics: An Insight into Recent Advances
Zahra Shafaghat,
Safa Radmehr,
Saber Saharkhiz
и другие.
Topics in Current Chemistry,
Год журнала:
2025,
Номер
383(2)
Опубликована: Май 9, 2025
Язык: Английский
Regulatory mechanism of circular RNAs in brain and neurodegenerative diseases
Mandana Amelimojarad,
Melika Amelimojarad
Frontiers in Molecular Neuroscience,
Год журнала:
2025,
Номер
18
Опубликована: Май 16, 2025
Recent
advancements
in
sequencing
technology
have
allowed
scientists
to
study
the
function
and
expression
of
different
non-coding
RNAs
(ncRNAs).
Circular
(circRNAs)
are
increasingly
recognized
as
prognostic
diagnostic
biomarkers.
These
classes
ncRNAs
closed
loops
that
made
from
alternative
mRNA
splicing
can
be
found
large
quantities
with
their
evolutionarily
conserved
features
across
species.
circRNAs
derived
both
coding
transcript
regulate
cellular
proteins
linear
transcripts
via
ability
act
miRNA
sponges
at
various
levels.
Different
affect
neurodegenerative
disease
pathogenesis
such
Alzheimer's
(AD),
altering
a
variety
methods.
However,
there
is
still
limited
knowledge
about
brain
cells.
Therefore,
this
review,
we
will
focus
on
role
reveal
new
potential
therapeutic
target
open
door
novel
therapies
improved
management
diseases.
Язык: Английский
Novel insights into the N 6-methyladenosine modification on circRNA in cancer
Frontiers in Oncology,
Год журнала:
2025,
Номер
15
Опубликована: Май 19, 2025
Circular
RNAs
(circRNAs)
are
a
class
of
non-coding
(ncRNAs)
generated
through
the
reverse
splicing
mRNA
precursors
(pre-mRNAs).
They
possess
unique
loop
structure
and
exhibit
remarkable
stability.
CircRNAs
have
emerged
as
promising
biomarkers
for
cancer,
with
specific
circRNAs
playing
crucial
roles
in
cancer
drug
discovery,
treatment,
resistance
mechanisms.
N6
methyl
adenosine
(m6A)
represents
most
prevalent
RNA
modification
eukaryotes.
In
2017,
researchers
identified
that
m6A
modifications
also
occur
circRNAs,
displaying
characteristics.
m6A-modified
undergo
reversible
regulation
mediated
by
enzymes
involved
pathways.
These
modified
interact
m6A-binding
proteins,
thereby
influencing
processes
such
alternative
splicing,
translation
degradation.
Some
enhance
their
metabolism
or
facilitate
nuclear
export
to
cytoplasm
interacting
regulation.
The
study
has
gained
great
attention
circRNA
research
due
association
various
diseases.
This
review
summarizes
functional
mechanisms
regulated
implications
occurrence
therapy,
primary
focus
on
genesis,
regulatory
mechanisms,
biology
diverse
types
cancers.
Additionally,
we
explore
potential
application
clinical
treatment.
Язык: Английский